Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Sr MD Chief Commercial Officer | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 31,561 |
Ending reported balance
After 2026-09-16 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-09-15 · Grant · Acquired 2,864 · Balance 32,974 F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service. Row 2 · 2026-09-15 · Tax withholding · Disposed 373 · Balance 32,601 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 3 · 2026-09-15 · Tax withholding · Disposed 361 · Balance 32,240 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 4 · 2026-09-15 · Tax withholding · Disposed 320 · Balance 31,920 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. Row 5 · 2026-09-16 · Tax withholding · Disposed 359 · Balance 31,561 F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments, subject to continued service.
F2: Represents shares surrendered to the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock previously granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2017 Filed Feb 28, 2017 17:06 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 855 | $0.00 Strike: $83.88 | $0.00 |
DisclosureSEC source: 0001156375-17-000020 · edgardoc.xml · derivative · entry 7 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,420 Underlying: Common Stock Class A · 855 shares Expires 2018-06-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: As of 6/16/2013, this option vested with respect to 100% of the granted number of shares covered by the option. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 2,875 | $122.56 | $352,351.95 |
DisclosureSEC source: 0001156375-17-000020 · edgardoc.xml · nonDerivative · entry 6 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,486 F1 · price: On February 24, 2017, Ms. Winkler sold a total of 2,875 shares of CME Group Class A common stock at an average price of $122.56 per share, including the exercise of options. The price ranges were $122.54 through $122.56. The Company maintains a record of the transactions and copies will be provided upon request. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:06 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 2,875 | $109.72 | $315,445.00 |
DisclosureSEC source: 0001156375-17-000020 · edgardoc.xml · nonDerivative · entry 5 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 855 | $122.41 | $104,659.18 |
DisclosureSEC source: 0001156375-17-000020 · edgardoc.xml · nonDerivative · entry 4 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,486 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:06 UTC | CME GROUP INC. CME · Entity 2909 | Exercise / conversionCommon Stock Class A | 855 | $83.88 | $71,717.40 |
DisclosureSEC source: 0001156375-17-000020 · edgardoc.xml · nonDerivative · entry 3 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 609 | $122.51 | $74,608.59 |
DisclosureSEC source: 0001156375-17-000020 · edgardoc.xml · nonDerivative · entry 2 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,486 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:06 UTC | CME GROUP INC. CME · Entity 2909 | SaleCommon Stock Class A | 1,549 | $122.56 | $189,845.44 |
DisclosureSEC source: 0001156375-17-000020 · edgardoc.xml · nonDerivative · entry 1 Winkler Julie · CIK 0001692514 · Sr MD Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,095 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.